Beer & Biotech
Incubator Life: Exploring the Elements a Startup Should Look For
Join us in welcoming Sally Allain, the Head of Johnson & Johnson Innovation – JLABS @ Washington, DC, and Interim Head, JLABS North East. With experience supporting biotech startups and external partnering for Johnson & Johnson Innovation, Allain will share her insights on the different features and value available at a healthcare & life sciences incubator. Additionally, Allain will address:
- What an early-stage biotech should consider when applying for an incubator?
- What can a company can expect during its time at an incubator?
- How can a company maximize the value of an incubator?
- Opportunities with J&J Innovation – JLABS
Allain will also share insights into the trends that Johnson and Johnson Innovation is seeing for biotech and early-stage companies in 2023.
About the Speaker
Sally Allain, MBA, MSc.
Head of Johnson & Johnson Innovation – JLABS @ Washington, DC, and Interim Head, JLABS North East
As Head of JLABS @ Washington, DC, Sally sets the strategic direction and oversees all operational activities for JLABS in the greater Washington metro region, including Maryland and Virginia. In this role, Sally is responsible for the process of evaluating and selecting a strong portfolio of innovators for JLABS @ Washington, DC, and building strategic partnerships with corporate, academic, government and industry organizations that aim to strengthen the region’s life sciences innovation network.
Sally joined JLABS after serving as Senior Director, Strategy & Operations on the Global External Innovation team at Johnson & Johnson, where she supported portfolio management and reporting and strategic business development efforts across the organization. Prior, Sally was with Janssen R&D, Immunology, where she managed a team in research operations and alliance management for the early discovery to early development portfolio. Sally understands well the needs of healthcare entrepreneurs, having launched her research career at a San-Diego based biotech startup and then working internationally for a UK-based governmental economic development agency creating early-stage biotech and academic collaborative programs aimed at accelerating the development of products to address the needs of patients and consumers.
Sally received her MBA from the University of California Berkeley, Haas School of Business; a Master of Science Degree in Microbiology / Immunology from Virginia Tech; and a Bachelor of Science Degree in Biology from Virginia Tech. She sits on the Boards of BioHealth Innovation and Mindshare, two organizations supporting the success of emerging companies in the DMV region, and she is an Executive Fellow at the Economic Club of Washington, DC.